Wockhardt gets USFDA nod for Ceftriaxone injection

Mumbai, May 15 (UNI) Pharmaceutical and biotechnology major Wockhardt today said it has received approval of US Federal Drug Authority (FDA) for marketing Ceftriaxone Sodium injection in the United States.

The company's US subsidiary, Wockhardt USA Inc., is expected to launch the broad-spectrum cephalosporin antibiotic in the next few weeks, it added.

'' The approval marks Wockhardt's entry into the US injectables market,'' said Wockhardt Chairman Habil Khorakiwala. '' This is the first out of nine injectables that we have filed with the US FDA. We expect to launch several more products, including injectables in the US this year.'' With Ceftriaxone, Wockhardt now has 12 products in the US market, and is waiting for approval of over 20 products from USFDA, the company release said.

UNI SA SKB1800